The Value Proposition of Liquid Biopsy in the Clinical Setting
Date: Thursday September 4th, 2025, 1-2:30pm Eastern Daylight Time
Speaker
Patrice Desmeules MD, MSc, FRCPC, DABP
Anatomic and molecular pathologist
Québec Heart and Lung Institute
Institut Universitaire de Cardiologie et de Pneumologie de Québec
Université Laval
I am an anatomic and molecular pathologist at IUCPQ-UL/Quebec Heart and Lung Institute since 2017 after training in anatomic pathology at Université Laval followed by fellowships in oncologic surgical and thoracic molecular pathology at Memorial Sloan Kettering Cancer Center, NY. My interests are focused on translational research and biomarkers in thoracic neoplasms.
Guest Host & Moderator
Heather Ruff DO, MPH, FCAP
Pathologist, Saskatchewan Health Authority
Section Editor, Cytopathology, CBQAReadout.ca
Learning Objectives:
After this episode, the participant will be able to:
- List the current guidelines for the use of liquid biopsy in clinical settings for NSCLC.
- Describe the resource implications of implementing liquid biopsy versus traditional methods.
- Describe the considerations to favor endorsement of liquid biopsy assays in the public health system.